Gene · 8322
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 | 36189423 | PubTator, text mining | PubMed |
| Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental development and preeclampsia. | Front Cell Dev Biol | 2022 | 36187484 | PubTator, text mining | PubMed |
| Circular RNAs in Diabetic Nephropathy: Updates and Perspectives. | Aging Dis | 2022 | 36186139 | PubTator, text mining | PubMed |
| Heavy-load exercise in older adults activates vasculogenesis and has a stronger impact on muscle gene expression than in young adults. | Eur Rev Aging Phys Act | 2022 | 36182918 | PubTator, text mining | PubMed |
| Sea anemone Frizzled receptors play partially redundant roles in oral-aboral axis patterning. | Development | 2022 | 36178132 | PubTator, text mining | PubMed |
| Multiomics analysis reveals the mechanical stress-dependent changes in trabecular meshwork cytoskeletal-extracellular matrix interactions. | Front Cell Dev Biol | 2022 | 36176278 | PubTator, text mining | PubMed |
| Multi-context genetic modeling of transcriptional regulation resolves novel disease loci. | Nat Commun | 2022 | 36171194 | PubTator, text mining | PubMed |
| A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways. | Aging (Albany NY) | 2022 | 36170021 | PubTator, text mining | PubMed |
Exploring the mutational landscape of genes associated with inherited retinal disease using large genomic datasets: identifying loss of function intolerance and outlying propensities for missense changes. | BMJ Open Ophthalmol | 2022 | 36161854 | PubTator, text mining | PubMed |
| Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. | J Bone Miner Res | 2022 | 36153665 | PubTator, text mining | PubMed |
| SZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy. | Transl Vis Sci Technol | 2022 | 36149648 | PubTator, text mining | PubMed |
| Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis. | Front Microbiol | 2022 | 36147849 | PubTator, text mining | PubMed |
| Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Oral Cancer. | Vaccines (Basel) | 2022 | 36146567 | PubTator, text mining | PubMed |
| RPE65 c.353G>A, p.(Arg118Lys): A Novel Point Mutation Associated with Retinitis Pigmentosa and Macular Atrophy | Int J Mol Sci | 2022 | 36142423 | PubTator, text mining | PubMed |
| Identification of Epigenetic Interactions between miRNA and Gene Expression as Potential Prognostic Markers in Bladder Cancer. | Genes (Basel) | 2022 | 36140796 | PubTator, text mining | PubMed |
| β2-Integrin Adhesive Bond Tension under Shear Stress Modulates Cytosolic Calcium Flux and Neutrophil Inflammatory Response. | Cells | 2022 | 36139397 | PubTator, text mining | PubMed |
| Systematic analysis of MCM3 in pediatric medulloblastoma via multi-omics analysis. | Front Mol Biosci | 2022 | 36133906 | PubTator, text mining | PubMed |
Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway. | Oncol Rep | 2022 | 36129153 | PubTator, text mining | PubMed |
| Potential epigenetic molecular regulatory networks in ocular neovascularization. | Front Genet | 2022 | 36118885 | PubTator, text mining | PubMed |
| Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma. | Int J Gen Med | 2022 | 36118184 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8322/papers?page=21